ALTx Therapeutics
PrivateLast Round
Accelerator
Feb 5, 2026
Total Funding Raised
$17.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ALTx Therapeutics operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Accelerator round in February 2026.
ALTx Therapeutics is a drug discovery company that develops precision cancer therapies targeting the Alternative Lengthening of Telomeres (ALT) pathway.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ALTx Therapeutics Comparables
Compare ALTx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tessellate BIO | 89% | |
| Artios Pharma | 72% | |
| FoRx Therapeutics | 71% |
For institutional investors. Book with your work email.
ALTx Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
ALTx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Syncona | Accelerator |
| The Francis Crick Institute | Accelerator |
| Cancer Research Horizons | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2026
$17M raised with participation from Syncona and Cancer Research Horizons.
For institutional investors. Book with your work email.
ALTx Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ALTx Therapeutics's valuation, stock price, and market status.
Is ALTx Therapeutics a public or private company?
ALTx Therapeutics is a private company.
What is the current stock price of ALTx Therapeutics?
ALTx Therapeutics is a private company, so its shares have no public market price. Caplight tracks ALTx Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ALTx Therapeutics worth (valuation)?
Valuation information for ALTx Therapeutics is not publicly available.
Can I buy ALTx Therapeutics stock?
ALTx Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ALTx Therapeutics's last funding round?
ALTx Therapeutics's most recent funding round was Accelerator on February 5, 2026.
Who are the main investors in ALTx Therapeutics?
Key investors in ALTx Therapeutics include Syncona, The Francis Crick Institute, Cancer Research Horizons.
Will ALTx Therapeutics IPO soon?
No public IPO plans have been announced for ALTx Therapeutics.
How can I track ALTx Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in ALTx Therapeutics's shares on secondary markets.